Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
0(0%)
Results Posted
50%(1 trials)

Phase Distribution

Ph not_applicable
1
33%
Ph phase_4
1
33%
Ph early_phase_1
1
33%

Phase Distribution

1

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution3 total trials
Early Phase 1First-in-human
1(33.3%)
Phase 4Post-market surveillance
1(33.3%)
N/ANon-phased studies
1(33.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

3

all time

Status Distribution
Active(1)
Completed(2)

Detailed Status

Completed2
Enrolling by invitation1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
0
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Early Phase 11 (33.3%)
Phase 41 (33.3%)
N/A1 (33.3%)

Trials by Status

enrolling_by_invitation133%
completed267%

Recent Activity

0 active trials
Showing 3 of 3
enrolling_by_invitationearly_phase_1

Treating Early Stage Diabetic Retinopathy

NCT05132660
completedphase_4

Effect of Long-acting Levodopa on Obstructive Sleep Apnea in Parkinson's Disease

NCT03111485
completednot_applicable

The Effect of Pramipexole on Metabolic Network Activity Compared With Levodopa in Early Parkinson's Disease

NCT01470859

Clinical Trials (3)

Showing 3 of 3 trials
NCT05132660Early Phase 1

Treating Early Stage Diabetic Retinopathy

Enrolling By Invitation
NCT03111485Phase 4

Effect of Long-acting Levodopa on Obstructive Sleep Apnea in Parkinson's Disease

Completed
NCT01470859Not Applicable

The Effect of Pramipexole on Metabolic Network Activity Compared With Levodopa in Early Parkinson's Disease

Completed

All 3 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
3